Erenumab is not associated with significant reductions in weekly attacks in patients with chronic cluster headache vs placebo ...

Patients with migraine discontinued treatment less often with atogepant and experienced a greater reduction in mean monthly ...

Although anti-calcitonin gene-related peptides are safe and efficacious for adolescents with chronic migraine, access to treatment is often subject to extended insurance authorization delays, ...

Meanwhile, Amgen and partner don’t seem to be testing erenumab in cluster headache, with no trials in that indication listed on clinicaltrials.gov or their respective pipeline tables.

SNS Insider Reveals Sharp Growth in U.S. Retinal Biologics Market, Valued at USD 9.70 Billion in 2023 Capturing Over 43% Global Share Amid FDA Approvals, VEGF-A Dominance, and Accelerating R&D in ...

Primary care clinicians focus on acute migraine management, despite the chronic nature of this neurological disease.

Find out what's happening in the market, today from undefined by undefined.

Find out what's happening in the market, today.

Erenumab Not Effective for Chronic Cluster Headache Erenumab is not associated with significant reductions in weekly attacks in patients with chronic cluster headache vs placebo, a new phase 2 ...

Follow the latest President Trump news stories and headlines. Get breaking news alerts when you download the ABC News App and subscribe to President Trump notifications.

Reuters.com is your online source for the latest Europe news stories and current events, ensuring our readers up to date with any breaking news developments ...

Find latest aerospace news from every corner of the globe at Reuters.com, your online source for breaking international news coverage.